Results 11 to 20 of about 29,630 (214)

Effect of Glycerol on Fosfomycin Activity against Escherichia coli

open access: yesAntibiotics, 2022
Fosfomycin is an antimicrobial that inhibits the biosynthesis of peptidoglycan by entering the bacteria through two channels (UhpT and GlpT). Glycerol is clinically used as a treatment for elevated intracranial pressure and induces the expression of glpT
Miriam Ortiz-Padilla   +6 more
doaj   +1 more source

Fosfomycin in Osteomyelitis [PDF]

open access: yesChemotherapy, 1976
Fosfomycin was exclusively used as antibiotic treatment in 37 patients suffering from osteomyelitis, out ot which 23 were operated for sequestrectomy or fistulectomy, whereas the remaining 14 did not undergo any surgery during fosfomycin treatment. Fosfomycin was adminsitered parenterally, alone or combined with oral administration, and in some cases ...
J E, Fernandez-Valencia   +3 more
openaire   +2 more sources

The revival of fosfomycin [PDF]

open access: yesInternational Journal of Infectious Diseases, 2011
Fosfomycin, originally named phosphonomycin, was discovered in Spain in 1969. There are three forms of fosfomycin: fosfomycin tromethamine (a soluble salt) and fosfomycin calcium for oral use, and fosfomycin disodium for intravenous use. Fosfomycin is a bactericidal antibiotic that interferes with cell wall synthesis in both Gram-positive and Gram ...
Michalopoulos, Argyris S.   +2 more
openaire   +2 more sources

The Combination of Daptomycin with Fosfomycin is More Effective than Daptomycin Alone in Reducing Mortality of Vancomycin-Resistant Enterococcal Bloodstream Infections: A Retrospective, Comparative Cohort Study

open access: yesInfectious Diseases and Therapy, 2023
Introduction High-dose daptomycin-based combinations are recommended for vancomycin-resistant Enterococcus (VRE) bloodstream infection (BSI). Preclinical data have shown a synergistic effect of daptomycin/fosfomycin combinations against VRE.
Tai-Chung Tseng   +7 more
doaj   +1 more source

Asp50Glu mutation in MurA results in fosfomycin resistance in Enterococcus faecium

open access: yesJournal of Global Antimicrobial Resistance, 2022
: Objectives: Enterococcus faecium is one of the important pathogens causing nosocomial infection, which can be resistant to fosfomycin by obtaining the plasmid-encoded fosfomycin resistance genes, and the mutation of MurA protein encoded by chromosome ...
Ling Xin   +7 more
doaj   +1 more source

Fosfomycin Resistance in Escherichia coli Isolates from South Korea and in vitro Activity of Fosfomycin Alone and in Combination with Other Antibiotics

open access: yesAntibiotics, 2020
We investigated fosfomycin susceptibility in Escherichia coli clinical isolates from South Korea, including community-onset, hospital-onset, and long-term care facility (LTCF)-onset isolates.
Hyeri Seok   +5 more
doaj   +1 more source

Phosphonopeptides Revisited, in an Era of Increasing Antimicrobial Resistance [PDF]

open access: yes, 2020
Given the increase in resistance to antibacterial agents, there is an urgent need for the development of new agents with novel modes of action. As an interim solution, it is also prudent to reinvestigate old or abandoned antibacterial compounds to assess
Anderson, Rosaleen   +8 more
core   +2 more sources

Molecular mechanisms and epidemiology of fosfomycin resistance in enterococci isolated from patients at a teaching hospital in China, 2013–2016

open access: yesJournal of Global Antimicrobial Resistance, 2020
Objectives: The aim of this study was to investigate the mechanisms of fosfomycin resistance and epidemiological characteristics in fosfomycin-resistant enterococci in China.
Xiucai Zhang   +6 more
doaj   +1 more source

In vitro activity of fosfomycin against Campylobacter isolates from poultry and wild birds. [PDF]

open access: yesPLoS ONE, 2018
Fosfomycin is a broad-spectrum antibiotic with the activity against both Gram-positive and Gram-negative pathogens by inhibiting the bacterial cell wall synthesis. Given the potential therapeutic efficacy of fosfomycin against Campylobacter spp., the aim
Bai Wei, Min Kang
doaj   +1 more source

fosA3 overexpression with transporter mutations mediates high-level of fosfomycin resistance and silence of fosA3 in fosfomycin-susceptible Klebsiella pneumoniae producing carbapenemase clinical isolates.

open access: yesPLoS ONE, 2020
The effective treatment of carbapenemase-producing Klebsiella pneumoniae infection has been limited and required novel potential agents. Due to the novel drug development crisis, using old antimicrobial agents and combination therapy have been ...
Uthaibhorn Singkham-In   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy